« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 6
, Pages 750-757
, 15 September 2009
Acute Effects of Statin Therapy on Coronary Atherosclerosis Following an Acute Coronary Syndrome
References
- . Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504
- . Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study; a randomized controlled trial. JAMA. 2001;285:1711–1718
- . Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430–436
- . Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet. 2001;357:1063–1068
- . Intravascular ultrasound assessment of atherosclerosis. Curr Atheroscler Rep. 2004;6:219–224
- . Application of intravascular ultrasound in anti-atherosclerotic drug development. Nat Rev Drug Discov. 2006;5:485–492
- . Regression of coronary atherosclerosis by simvastatin (A serial intravascular ultrasound study). Circulation. 2004;110:265–270
- . Effect of very high-intensity statin therapy on regression of coronary atherosclerosis (The ASTEROID trial). JAMA. 2006;295:1556–1565
- . Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis (A randomized controlled trial). JAMA. 2004;291:1071–1080
- . Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis (A randomized controlled trial). JAMA. 2007;297:1675–1682
- . Early statin treatment in patients with acute coronary syndrome (Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study). Circulation. 2004;110:1061–1068
- . Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005;46:1405–1410
- . Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?. Am J Cardiol. 2005;96(suppl 5A):54F–60F
- . A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation. 2006;113:1406–1414
- . Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29–38
- . Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297:499–508
- . Total cholesterol/HDL cholesterol ratio vs. LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med. 2001;161:2685–2692
- . Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease (An 8-year follow-up in the Copenhagen Male Study). Arterioscler Thromb Vasc Biol. 1997;17:1114–1120
- . Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease (The RISCA (Recurrence and Inflammation in the Acute Coronary Syndromes) study). J Am Coll Cardiol. 2008;51:2339–2346
This study was supported by the Cardiovascular Health Network of the Fonds de la Recherche en Santé du Québec, Montreal, Quebec, Canada. The ERASE trial was funded by CSL Ltd, Parkeville, Victoria, Australia.
PII: S0002-9149(09)01044-3
doi: 10.1016/j.amjcard.2009.05.009
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 6
, Pages 750-757
, 15 September 2009
